BackGracell Biotechnologies Overview

Gracell Biotechnologies Accounts Payable

Track Gracell Biotechnologies's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average

Loading

Gracell Biotechnologies Accounts Payable History

Loading

Gracell Biotechnologies vs. peers: Accounts Payable Comparison

Loading

Gracell Biotechnologies Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gracell Biotechnologies (GRCL) FAQ

As of the most recent data (September 2023), GRCL shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRCL's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Gracell Biotechnologies is outperforming or lagging.

Tracking GRCL's accounts payable over time shows whether Gracell Biotechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Gracell Biotechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

Gracell Biotechnologies's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.